Filing Flows

Filing Flows › Orchestra BioMed Holdings (OBIO) › Next earnings date

Orchestra BioMed Holdings (OBIO) earnings on Nov 9, 2026: what to expect

Orchestra BioMed Holdings (OBIO) is expected to report earnings on Nov 9, 2026 (estimated), tomorrow, for the quarter ending Sep 30, 2026. Analysts expect EPS of −$0.40 (−$0.45 to −$0.37, 6 estimates) on revenue of $104K, against −$0.40 and $861K a year ago. It beat the EPS estimate in 100% of the quarters on record; Filing Flows' model gives it a 83% chance of beating next time.

Report dateNov 9, 2026 (estimated)
Days to go1
EPS estimate−$0.40
Revenue estimate$104K
Beat rate100%

What to watch

Last quarter (Q2 2026) the lines that make up revenue grew like this; the report shows whether the trend holds:

Orchestra BioMed Holdings: revenue lines, growth year over year, Q2 2026Orchestra BioMed Holdings: revenue lines, growth year over year, Q2 2026Revenue-89%

Filing Flows' own estimate from the SEC figures — the same quarter last year times recent growth — is EPS −$0.40 on revenue of $441K, against the analysts' −$0.40.

The last report

Orchestra BioMed Holdings reported revenue of $88K for the second quarter 2026 (-90% Y/Y), net loss $23.8M. How it makes money → · Every quarter →

Orchestra BioMed Holdings: EPS against the estimate, last 3 reportsOrchestra BioMed Holdings: EPS against the estimate, last 3 reportsEstimateReported−$0.43−$0.40Nov 25−$0.38$0.26Mar 26−$0.37−$0.37Aug 26
Latest (Aug 26): Estimate −$0.37, Reported −$0.37.

Orchestra BioMed Holdings' latest quarter

Orchestra BioMed Holdings, Q2 2026: revenue $88K (-90% year over year), net loss $23.8M, operating cash flow −$19.3M. The chart follows the revenue to costs, profit and cash.

Questions

When does OBIO report earnings?

Orchestra BioMed Holdings is expected to report on Nov 9, 2026 (estimated).

What are analysts expecting from Orchestra BioMed Holdings?

EPS of −$0.40 and revenue of $104K for the quarter.

Does Orchestra BioMed Holdings usually beat earnings?

It beat the consensus EPS estimate in 100% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.